Vectormune FP ILT

Valsts: Eiropas Savienība

Valoda: franču

Klimata pārmaiņas: EMA (European Medicines Agency)

Aktīvā sastāvdaļa:

recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live

Pieejams no:

CEVA-Phylaxia Co. Ltd.

SNN (starptautisko nepatentēto nosaukumu):

Fowlpox and avian infectious laryngotracheitis vaccine (live, recombinant)

Ārstniecības grupa:

poulet

Ārstēšanas norādes:

For active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Autorizācija statuss:

Autorisé

Autorizācija datums:

2020-12-09

Lietošanas instrukcija

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Des informations à jour sur ce médicament à usage vétérinaire
sont disponibles sur le site web
d’information sur les médicaments à usage vétérinaire.

Produkta apraksts

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Des informations à jour sur ce médicament à usage vétérinaire
sont disponibles sur le site web
d’information sur les médicaments à usage vétérinaire.